CME Group
$263.14Change from previous close: −0.74%Absolute change: −$1.96
At a glance
- Revenue growth
- +6.32%
- 2025 vs 2024
- Net income growth
- +15.50%
- 2025 vs 2024
- Net margin
- 62.6%
- 2024: 57.6%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4,277 | 3,691 | 3,454 | 3,056 | 2,402 | 2,716 | 2,673 | 2,441 | 1,751 | 1,732 |
| Depreciation and amortization | 331 | 337 | 353 | 363 | 385 | 464 | 473 | 249 | 209 | 225 |
| Capital expenditure | -83.5 | -94.0 | -76.4 | -89.7 | -127 | -198 | -246 | -117 | -81.9 | -91.8 |
| Investing cash flow | 1,499 | -82.6 | 20.9 | -490 | 58.4 | -176 | -153 | -1,890 | 180 | 53.7 |
| Financing cash flow | 56,510 | 5,077 | -48,339 | -25,382 | 69,909 | 47,247 | -4,719 | -1,080 | -1,985 | -1,621 |
| Dividends paid | -3,933 | -3,584 | -3,236 | -2,634 | -2,189 | -2,110 | -1,696 | -2,150 | -1,994 | -1,787 |
| Share repurchases | -300 | -33.0 | -21.4 | -24.8 | -31.7 | -41.4 | -36.8 | -35.0 | -31.3 | -26.8 |
| Debt issued | 741 | 0.0 | 0.0 | 741 | — | — | — | 1,572 | — | 130 |
| Debt repaid | -750 | 0.0 | -16.4 | -756 | — | -305 | -662 | -453 | — | — |
| Net change in cash | 62,285 | 8,684 | -44,865 | -22,816 | 72,370 | 49,787 | -2,199 | -529 | -54.3 | 165 |
| Free cash flow | 4,194 | 3,597 | 3,377 | 2,966 | 2,275 | — | — | — | — | — |
| Levered free cash flow | 837 | 2,681 | 2,566 | 2,702 | 2,044 | 1,987 | 2,143 | 1,305 | 1,444 | 1,693 |